Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;27(11):1642-1660.
doi: 10.2174/0113862073290831240229060932.

DPP2/7 is a Potential Predictor of Prognosis and Target in Immunotherapy in Colorectal Cancer: An Integrative Multi-omics Analysis

Zhihao Shang  1 , Yueyang Lai  1 , Haibo Cheng  1
Affiliations

DPP2/7 is a Potential Predictor of Prognosis and Target in Immunotherapy in Colorectal Cancer: An Integrative Multi-omics Analysis

Zhihao Shang et al. Comb Chem High Throughput Screen. 2024.

Abstract

Background: Colorectal cancer (CRC) ranks among the leading causes of cancerrelated deaths.

Objective: This study aimed to illuminate the relationship between DPP7 (also known as DPP2) and CRC through a combination of bioinformatics and experimental methodologies.

Methods: A multi-dimensional bioinformatic analysis on DPP7 was executed, covering its expression, survival implications, clinical associations, functional roles, immune interactions, and drug sensitivities. Experimental validations involved siRNA-mediated DPP7 knockdown and various cellular assays.

Results: Data from the Cancer Genome Atlas (TCGA) identified high DPP7 expression in solid CRC tumors, with elevated levels adversely affecting patient prognosis. A shift from the N0 to the N2 stage in CRC was associated with increased DPP7 expression. Functional insights indicated the involvement of DPP7 in cancer progression, particularly in extracellular matrix disassembly. Immunological analyses showed its association with immunosuppressive entities, and in vitro experiments in CRC cell lines underscored its oncogenic attributes.

Conclusion: DPP7 could serve as a CRC prognosis marker, functioning as an oncogene and representing a potential immunotherapeutic target.

Keywords: Dipeptidyl Peptidase 7; bioinformatics; colorectal cancer; immunotherapy; oncogene; prognosis..

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Ye W.; Ling S.; Liu R.Y.; Pan Z.Z.; Wang G.; Gao S.; Wu J.; Cao L.; Dong L.; Li Y.; Zhou Y.; Du W.; Meng X.; Chen J.; Guan X.; He Y.; Pan C.; Zheng X.F.S.; Lu X.; Chen S.; Huang W.; Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers. J Pathol 2018,245(2),222-234 - DOI - PubMed
    1. Wiig J.N.; Poulsen J.P.; Tveit K.M.; Olsen D.R.; Giercksky K.E.; Intra-operative irradiation (IORT) for primary advanced and recurrent rectal cancer. Eur J Cancer 2000,36(7),868-874 - DOI - PubMed
    1. He C.; Duan X.; Guo N.; Chan C.; Poon C.; Weichselbaum R.R.; Lin W.; Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun 2016,7(1),12499 - DOI - PubMed
    1. Waumans Y.; Baerts L.; Kehoe K.; Lambeir A.M.; De Meester I.; The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis. Front Immunol 2015,6,387 - DOI - PubMed
    1. Ng L.; Foo D.C.C.; Wong C.K.H.; Man A.T.K.; Lo O.S.H.; Law W.L.; Repurposing DPP-4 inhibitors for colorectal cancer: A retrospective and single center study. Cancers 2021,13(14),3588 - DOI - PubMed

MeSH terms

Substances